Major Growth Driver Identified in 2025 Stem Cell Therapy Market: Increasing Prevalence Of Chronic Diseases To Drive Market Growth

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Stem Cell Therapy Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of stem cell therapy has seen a swift expansion in the past few years. It is projected to increase from $7.86 billion in 2024 to $9.26 billion in 2025, registering a compound annual growth rate (CAGR) of 17.7%. The significant progression during the past period is a reflection of the escalating occurrence of chronic illnesses, increased financial support from government and private institutions, the fast-paced growth of emerging markets, a hike in investments committed to cell and gene therapies, a surge in healthcare spending, as well as an amplified pharmaceutical research and development investment.

Stem Cell Therapy Market Size Forecast: What's the Projected Valuation by 2029?
Rapid advancement is expected in the stem cell therapy market size in the upcoming years, with it likely to reach a valuation of "$14.6 billion in 2029, showing a compound annual growth rate (CAGR) of 12.1%. The surge during the forecast period can be connected to an increase in government backing, a swift rise in the older population, an uptick in research and development expenditure, and a surge in healthcare spending. Key trends throughout the forecast period involve a focus on detailed scrutiny of advancements in mesenchymal stem cell therapy to leverage innovative breakthroughs in the sector, market players should seek partnerships and acquisitions to promote product innovation and revenue growth, companies ought to invest in the development of ipsc-derived nk cells for patient treatment, the entities working in the stem cell therapy market should emphasize the development of stem cell therapy, particularly for cancer to establish a competitive edge over somatic cell contenders, and the businesses operating in the stem cell therapy market should tap into artificial intelligence to enhance product quality, safety, and manufacturing efficiency.

View the full report here:
https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

What Are the Drivers Transforming the Stem Cell Therapy Market?
The surge in chronic diseases has fueled the expansion of the stem cell therapy market. Long hours spent working, a lack of physical exercise, and poor dietary habits are factors that increase the incidence of chronic diseases among individuals, thereby prompting the demand for stem cell therapy. As per an article from the United Nations, chronic diseases are projected to account for 70% of all deaths globally by 2030. The overall chronic disease load is predicted to hit approximately 60%. The growing incidence of chronic diseases is anticipated to propel the growth of the stem cell therapy market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3399&type=smp

What Long-Term Trends Will Define the Future of the Stem Cell Therapy Market?
Strategic partnerships are becoming an increasingly popular investment choice for businesses in the stem cell therapy market. This type of partnership represents a mutually advantageous agreement between two businesses that aren't in direct competition. For example, SQZ Biotechnologies, an American biotechnology firm, formed a partnership with STEMCELL Technologies Inc., a Canadian biotech company, in May 2022. They aim to develop and commercialize a research-use-only (RUO) microfluidic intracellular delivery system through this collaboration. This system will leverage SQZ's Cell Squeeze technology and enhance cell engineering capabilities for preclinical research within the life sciences community. Both enterprises will unveil significant discoveries on the RUO system's efficiency in cargo delivery to primary immune cell types, as well as progress made in cell engineering using mRNA and CRISPR/Cas9 in hematopoietic stem cells.

Which Segments in the Stem Cell Therapy Market Offer the Most Profit Potential?
The stem cell therapy market covered in this report is segmented -

1) By Type: Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy
2) By Cell Source: Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells
3) By Application: Musculoskeletal Disorders and Wounds & Injuries, Cancer, Autoimmune Disorders, Others
4) By End-Users: Hospitals And Clinics, Research Centers, Others.

Subsegments:
1) By Allogeneic Stem Cell Therapy: Derived From Donors (Related Or Unrelated), Used For Various Conditions, Including Blood Disorders And Certain Cancers, Examples Include Umbilical Cord Blood Stem Cells And Peripheral Blood Stem Cells
2) By Autologous Stem Cell Therapy: Derived From The Patient's Own Cells, Used For Conditions Such As Orthopedic Injuries, Cardiac Diseases, And Certain Cancers, Involves The Harvesting Of Stem Cells From Tissues Like Bone Marrow Or Adipose Tissue

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3399&type=smp

Which Firms Dominate the Stem Cell Therapy Market by Market Share and Revenue in 2025?
Major companies operating in the stem cell therapy market include Fujifilm Holding Corporation, Thermo Fisher Scientific Inc., Takara Bio Inc., MEDIPOST Co., Ltd., Astellas Pharma Inc., Catalent, Inc., Pharmicell Co., Ltd., JCR Pharmaceuticals Co., Ltd., Stemedica Cell Technologies, Inc., Pluristem Technologies Ltd, Becton Dickinson Private Limited, Stem Cell Technologies India Pvt. Ltd, Cordlife India Pvt. Ltd, Lifecell International Pvt. Ltd, Stemcyte India Therapeutics Private Limited, Stempeutics Research Private Limited, Anterogen Co., Ltd, Tonghua Dongbao Pharmaceutical Co, China Biologic Products Holdings Inc, Astrazenaca, Ablbio, Henlius, China Regenerative Medicine International, Innovent Biologics, Bio-Thera, Hisun Pharma, 3sbio, Beijing Shuanglu Pharmaceuticals, Qilu Pharmaceutical, Shanghai Fosun Pharmaceuticals, Cellerix, Cellgenix, Nsgene, Tigenix, Renuron Group, Smart Cells And Genenta Science, Amsterdam Molecular Therapeutics (Amt), Ark Therapeutics, Arthrogen Bv, Diamyd Medical Ab, Oxford Biomedica, Transgene, Mabion, Pure Biologics, Oncoarendi Therapeutics, Celon Pharma, Becton Dickinson And Company, Osiris Therapeutics, Capricortherapeutics, Cellular Dynamics Discgenics, Takeda Pharmaceuticals, Kolon Tissue Gene, Athersys, Cyro-Cell International, Geron Corporation, Mesoblast Ltd, Astrom Biosciences Inc, Invitrogen, Cytori Therapeutics Inc, Nuvasive Inc, Bristol-Myers Squibb Aldagen Inc, Caladrius Biosciences Inc, Biogen Sa, Daiichi Sankyo Co. Ltd, Gamida Cell Ltd, Gilead Sciences, Inc., Novartis Ag, Pfizer, Sanofi S.A.

Which Regions Offer the Highest Growth Potential in the Stem Cell Therapy Market?
North America was the largest region in the stem cell therapy market in 2024. The Middle East is expected to be the fastest-growing region in the global stem cell therapy market during the forecast period. The regions covered in the stem cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3399

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.